3 results
Approved WMOCompleted
To explore the safety, tolerability and the pharmacokinetic profile of 2-IB when given on top of therapeutic hypothermia.
Approved WMOCompleted
The primary objective of this study is to evaluate the short term safety and tolerability, and pharmacokinetic properties of 2-IB when administered to adult patients after OHCA. Secondary objectives include safety and efficacy parameters at 30 days…
Approved WMOCompleted
The objective of the study is to characterize the performance of biologically assisted core decompression performed with the PerFuse instrument and BioCUE for the treatment AVN of the femoral head. The study will explore the potential impact of…